Omeros (OMER) Amortization of Deferred Charges (2010 - 2025)
Omeros recorded quarterly Amortization of Deferred Charges of $8.7 million in Q4 2025, up 473.54% quarter-over-quarter from $1.5 million in Q3 2025, and up 260.77% year-over-year from $2.4 million in Q4 2024.
Omeros' Amortization of Deferred Charges history runs 16 years deep, the most recent figure standing at $8.7 million for Q4 2025.
- In Q4 2025, Amortization of Deferred Charges rose 260.77% year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $11.5 million (up 275.18% YoY), while the FY2025 annual figure was $3.9 million, up 184.28% from the prior year.
- Amortization of Deferred Charges came in at $8.7 million for Q4 2025 at Omeros, up from $1.5 million in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $8.7 million in Q4 2025 to a low of -$5.4 million in Q4 2024.
- A 5-year average of $462526.3 and a median of $440000.0 in 2021 frame the typical range for Amortization of Deferred Charges.
- On a YoY basis, Amortization of Deferred Charges climbed as much as 950.0% in 2025 and fell as far as 719.48% in 2025.
- Omeros' Amortization of Deferred Charges stood at $440000.0 in 2021, then plunged by 409.32% to -$1.4 million in 2022, then surged by 236.15% to $1.9 million in 2023, then tumbled by 391.1% to -$5.4 million in 2024, then jumped by 260.77% to $8.7 million in 2025.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $8.7 million, $1.5 million, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.67 Mn |
| Dec 31, 2025 | 8.67 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Mar 31, 2025 | -1.91 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Dec 31, 2024 | -5.39 Mn |
| Sep 30, 2024 | 144,000.00 |
| Sep 30, 2024 | 144,000.00 |
| Jun 30, 2024 | 599,000.00 |
| Jun 30, 2024 | 599,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Dec 31, 2023 | 1.85 Mn |
| Dec 31, 2023 | 1.85 Mn |
| Jun 30, 2023 | -477,000.00 |
| Jun 30, 2023 | -477,000.00 |
| Mar 31, 2023 | 477,000.00 |
| Mar 31, 2023 | 477,000.00 |
| Dec 31, 2022 | -1.36 Mn |
| Dec 31, 2022 | -1.36 Mn |
| Sep 30, 2022 | 461,000.00 |
| Sep 30, 2022 | 461,000.00 |
| Jun 30, 2022 | 454,000.00 |
| Jun 30, 2022 | 454,000.00 |
| Mar 31, 2022 | 446,000.00 |
| Mar 31, 2022 | 446,000.00 |
| Dec 31, 2021 | 440,000.00 |
| Dec 31, 2021 | 440,000.00 |
| Sep 30, 2021 | 434,000.00 |
| Sep 30, 2021 | 434,000.00 |
| Jun 30, 2021 | 426,000.00 |
| Jun 30, 2021 | 426,000.00 |
| Mar 31, 2021 | 396,000.00 |
| Mar 31, 2021 | 396,000.00 |
| Dec 31, 2020 | 3.48 Mn |
| Dec 31, 2020 | 3.48 Mn |
| Sep 30, 2020 | 3.01 Mn |
| Sep 30, 2020 | 3.01 Mn |
| Jun 30, 2020 | 2.63 Mn |
| Jun 30, 2020 | 2.63 Mn |
| Mar 31, 2020 | 2.53 Mn |
| Mar 31, 2020 | 2.53 Mn |
| Dec 31, 2019 | 2.44 Mn |
| Dec 31, 2019 | 2.44 Mn |
| Sep 30, 2019 | 2.36 Mn |
| Sep 30, 2019 | 2.36 Mn |
| Jun 30, 2019 | 2.23 Mn |
| Jun 30, 2019 | 2.23 Mn |
| Mar 31, 2019 | 2.20 Mn |
| Mar 31, 2019 | 2.20 Mn |
| Dec 31, 2018 | 1.33 Mn |
| Dec 31, 2018 | 1.33 Mn |
| Sep 30, 2018 | 1.81 Mn |
| Sep 30, 2018 | 1.81 Mn |
| Jun 30, 2018 | 1.42 Mn |
| Jun 30, 2018 | 1.42 Mn |
| Mar 31, 2018 | 1.09 Mn |
| Mar 31, 2018 | 1.09 Mn |
| Dec 31, 2017 | 1.13 Mn |
| Dec 31, 2017 | 1.13 Mn |
| Sep 30, 2017 | 1.04 Mn |
| Sep 30, 2017 | 1.04 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Jun 30, 2017 | 1.02 Mn |
| Mar 31, 2017 | 995,000.00 |
| Mar 31, 2017 | 995,000.00 |
| Dec 31, 2016 | 782,000.00 |
| Dec 31, 2016 | 782,000.00 |
| Sep 30, 2016 | 511,000.00 |
| Sep 30, 2016 | 511,000.00 |
| Jun 30, 2016 | 471,000.00 |
| Jun 30, 2016 | 471,000.00 |
| Mar 31, 2016 | 213,000.00 |
| Mar 31, 2016 | 213,000.00 |
| Dec 31, 2015 | 386,000.00 |
| Dec 31, 2015 | 386,000.00 |
| Sep 30, 2015 | 217,000.00 |
| Sep 30, 2015 | 217,000.00 |
| Jun 30, 2015 | 230,000.00 |
| Jun 30, 2015 | 230,000.00 |
| Mar 31, 2015 | 212,000.00 |
| Mar 31, 2015 | 212,000.00 |
| Dec 31, 2014 | 206,000.00 |
| Dec 31, 2014 | 206,000.00 |
| Sep 30, 2014 | 201,000.00 |
| Sep 30, 2014 | 201,000.00 |
| Jun 30, 2014 | 195,000.00 |
| Jun 30, 2014 | 195,000.00 |
| Mar 31, 2014 | 136,000.00 |
| Mar 31, 2014 | 136,000.00 |
| Dec 31, 2013 | 131,000.00 |
| Dec 31, 2013 | 131,000.00 |
| Sep 30, 2013 | 129,000.00 |
| Sep 30, 2013 | 129,000.00 |
| Jun 30, 2013 | 122,000.00 |
| Jun 30, 2013 | 122,000.00 |
| Mar 31, 2013 | 120,000.00 |
| Mar 31, 2013 | 120,000.00 |
| Dec 31, 2012 | 64,000.00 |
| Dec 31, 2012 | 64,000.00 |
| Sep 30, 2012 | 90,000.00 |
| Sep 30, 2012 | 90,000.00 |
| Jun 30, 2012 | 97,000.00 |
| Jun 30, 2012 | 97,000.00 |
| Mar 31, 2012 | 103,000.00 |
| Mar 31, 2012 | 103,000.00 |
| Dec 31, 2011 | 105,000.00 |
| Dec 31, 2011 | 105,000.00 |
| Sep 30, 2011 | 96,000.00 |
| Sep 30, 2011 | 96,000.00 |
| Jun 30, 2011 | 95,000.00 |
| Jun 30, 2011 | 95,000.00 |
| Mar 31, 2011 | 56,000.00 |
| Mar 31, 2011 | 56,000.00 |
| Dec 31, 2010 | 40,000.00 |
| Dec 31, 2010 | 40,000.00 |
| Sep 30, 2010 | 52,000.00 |
| Sep 30, 2010 | 52,000.00 |